ESR1 Mutations and Therapeutic Resistance in Metastatic Breast Cancer: Progress and Remaining Challenges

The authors summarize the pre-clinical characterisation of ESR1 mutations and their association with clinical outcomes in metastatic breast cancer and primary disease.